Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT00636662Completed

FLU A+B Nasal Swab Clinical Study

Role: lead

NCT03485313Terminated

Beta-hCG Test Reference Range Determination

Role: lead

NCT02591121Completed

Procalcitonin Test Reference Range Determination

Role: lead

NCT02191735Completed

RAMP 200 / RAMP Cardiovascular Tests at the Point-of-Care

Role: lead

All 4 trials loaded